Genomic Sequencing of COVID-19 Patients and Determination of Genetic Predisposition and Clinical Prognosis via Bioinformatics Techniques
The World Health Organization (WHO) declared the COVID-19 outbreak a global pandemic on March 11, 2020. Rapidly spreading across 188 different countries, the COVID-19 pandemic led to over 117 million cases and 2.6 million COVID-19-related deaths
Development of a SARS-CoV-2 RT-qPCR Based Variant-Comprehensive Testing Kit Panel
The acute respiratory disease caused by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first emerged in December 2019 in Wuhan, China, leading to a global pandemic of unprecedented scale. SARS-CoV-2 is highly
Post-Preclinical Process Development for Inactivated and Recombinant SARS-CoV-2 Vaccines
The high-yield production of inactivated and recombinant vaccines against the SARS-CoV-2 virus necessitates the development of modern and effective bioprocesses. In this regard, optimization strategies for both upstream and downstream